Project aim
The aim of the COMBIVET project is to establish an ERA Chair of Comparative Medicine under the Institute of Veterinary Medicine and Animal Sciences (IVMAS) at the Estonian University of Life Sciences (EMU).
COMBIVET
Comparative medicine has great untapped research potential as many of the health challenges faced by humans and animals are the same. This includes age-related diseases, cancer, neurodegenerative diseases, cardiovascular diseases, bone and joint diseases (e.g. osteoarthritis and osteoporosis) and metabolic diseases (e.g. diabetes and insulin resistance).
Thanks to these similarities, knowledge gained from studying and treating animal patients can be applied in humans while developing new diagnostic tools, vaccines and therapies for both humans and animals. As such, IVMAS seeks to establish the ERA Chair of Comparative Medicine in order to develop its competences and capacities in the research field and ultimately become one of the leading European research organizations in comparative medicine.
Thanks to these similarities, knowledge gained from studying and treating animal patients can be applied in humans while developing new diagnostic tools, vaccines and therapies for both humans and animals. As such, IVMAS seeks to establish the ERA Chair of Comparative Medicine in order to develop its competences and capacities in the research field and ultimately become one of the leading European research organizations in comparative medicine.
|
Acronym: COMBIVET Duration of the project: 01.09.2019 – 31.08.2024 (60 months) Programme: H2020 - Horizon 2020 Call identifier: H2020-WIDESPREAD-2018-04 Project number: 857418 Coordinator: Estonian University of Life Sciences (EMU). Project Coordinator is responsible for administrative functions related to the project. The project is coordinated by the Estonian University of Life Sciences. |
This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 857418
